Ascentage Pharma Group International
HKEX:6855

Watchlist Manager
Ascentage Pharma Group International Logo
Ascentage Pharma Group International
HKEX:6855
Watchlist
Price: 44 HKD 13.7% Market Closed
Market Cap: 13.9B HKD

Wall Street
Price Targets

Price Targets Summary
Ascentage Pharma Group International

Wall Street analysts forecast Ascentage Pharma Group International stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 52.7 HKD with a low forecast of 48.48 HKD and a high forecast of 57.75 HKD.

Lowest
Price Target
48.48 HKD
10% Upside
Average
Price Target
52.7 HKD
20% Upside
Highest
Price Target
57.75 HKD
31% Upside
Ascentage Pharma Group International Competitors:
Price Targets
DVYSR
Devyser Diagnostics AB
13% Upside
IONS
Ionis Pharmaceuticals Inc
90% Upside
688428
InnoCare Pharma Ltd
42% Upside
CMMB
Chemomab Therapeutics Ltd
289% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
32% Upside
BSLN
Basilea Pharmaceutica AG
122% Upside
6955
Shandong Boan Biotechnology Co Ltd
33% Upside
KRYS
Krystal Biotech Inc
40% Upside

Revenue
Forecast

Revenue Estimate
Ascentage Pharma Group International

For the last 6 years the compound annual growth rate for Ascentage Pharma Group International's revenue is 81%. The projected CAGR for the next 4 years is 80%.

81%
Past Growth
80%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ascentage Pharma Group International

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascentage Pharma Group International

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ascentage Pharma Group International's stock price target?
Price Target
52.7 HKD

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 52.7 HKD with a low forecast of 48.48 HKD and a high forecast of 57.75 HKD.

What is Ascentage Pharma Group International's Revenue forecast?
Projected CAGR
80%

For the last 6 years the compound annual growth rate for Ascentage Pharma Group International's revenue is 81%. The projected CAGR for the next 4 years is 80%.

Back to Top